General Practice · San Juan, PR
NPI
1699725010
Since 2006
Specialty
General Practice
Code 208D00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
361 Calle Sgto Luis Medina
San Juan, PR, 00918
Phone (787) 614-5231
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$981K
18,791 prescriptions
Company payments, 2025
$288
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Juan C Ramos Martinez prescribed most often to Medicare patients was Gabapentin, with 745 prescriptions and refills. In total Juan C Ramos Martinez wrote 18,791 Medicare prescriptions that cost $981K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-30.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Gabapentin Generic | 745 | 1,527 | 194 | $10K |
| Atorvastatin Calcium Generic | 718 | 1,599 | 205 | $7,884 |
| Simvastatin Generic | 623 | 1,543 | 174 | $6,401 |
| Losartan Potassium Generic | 536 | 1,340 | 172 | $6,866 |
| Levothyroxine Sodium Generic | 521 | 1,073 | 141 | $7,702 |
| Metformin Hcl Generic | 507 | 1,098 | 137 | $3,958 |
| Amlodipine Besylate Generic | 453 | 1,041 | 137 | $2,653 |
| Omeprazole Generic | 431 | 823 | 119 | $4,058 |
| Quetiapine Fumarate Generic | 397 | 651 | 89 | $4,836 |
| Sertraline Hcl Generic | 389 | 833 | 111 | $3,577 |
| Memantine Hcl Generic | 359 | 767 | 108 | $9,452 |
| Synthroid Levothyroxine Sodium | 357 | 707 | 87 | $33K |
| Donepezil Hcl Generic | 353 | 687 | 92 | $5,457 |
| Lisinopril Generic | 342 | 790 | 92 | $2,583 |
| Metoprolol Succinate Generic | 334 | 850 | 112 | $7,027 |
Brand drugs: 2,030 claims; generic drugs: 16,689 claims; opioid claims: 46.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Juan C Ramos Martinez $288 ($288 in general payments such as food, travel and fees) from 1 company. The largest payer was Revance Therapeutics, Inc. with $288.
| Company | Payments | Amount |
|---|---|---|
| Revance Therapeutics, Inc. | 2 | $288 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.